Trial Profile
A study investigating the effect of zoledronate and denosumab on vitamin D and concentration of Parathyroid hormone in patients with osteoporosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Dec 2015
Price :
$35
*
At a glance
- Drugs Denosumab (Primary) ; Zoledronic acid (Primary)
- Indications Osteoporosis
- Focus Pharmacodynamics
- 02 Dec 2015 New trial record